比毛毛更可爱的是毛毛的月月

Recent Comments

  • 盘莉: 屌丝中的一位飘过,在上海打拼,必须要有梦想的支撑
  • donglei: 上次见到两个新审评员,一个来自保诺科技,一个来自恒瑞。来自研发单位的也许会多起来。谢谢回复。
  • kevinhh: 深有感触,CDE审评员的药品评审经验是非常丰富的,但是平心而论CDE审评员当中具备企业研发经历的并不多,就跟GMP检查员很少从生产企业出来是一样的。我国应该建立一支审评员和检查员专职队伍,并且应放开渠道从生产企业招人,这才是技术监管的方向。 当然,现在的体制下,编制办给不了那么多的位置...
  • donglei: Brian,今天才看到你的评论呢,谢谢你的关注。
  • 盘莉: 哈哈,圣诞老人给清月准备了什么礼物啊?
  • 红魔: 那天在天桥上碰到清月,长大了喔,妈咪接放学还买好嘢食,哈哈,祝大家都happy啦!!!
  • brian: 毛毛,非常喜欢你从会上发的报道。特别是那篇讲述几名行业人士以及他们的感触,影响特深,过目不忘。将继续关注你的未来大作。

Random Posts

Tag Cloud

Interview with Dr.Paul Pomerantz

2010/03/04 – 10:00 上午

I had a cheeringly meet with Dr.Paul Pomerantz, Drug Information Association (DIA)’s new worldwide executive director last week in Beijing.Here are my questions:

Q1, What do you think of the first DIA China annual meeting? How do you rate it given the 100 points scale?

Q2, Could you share with us your career story? What’s your best achievements till now? Is there any experience that can be taken as a turning point for your life?

Q3. In the past years, is there anyone or anything that brings a major influence to your life?

Q4, Why did you join in DIA? Currently, What’s your focus and challenge in your work? What’s your expectation to yourself?

Q5, You once said, “drug is not only making medicines”, When you were appointed to be the executive director of DIA, could you share your points of drug development? How to meet the unmet clinical needs with patient oriented?

Q6, Last year, DIA set up its office in China, what’s your strategy here in China? What’s your expectation to China market given its unique healthcare system and pharmaceutical industry?

Q7, With more and more MNCs set up its R&D center today in China, China begins to play a big role in new drug development globally, What do you think of this? What’s the strength and weakness of China compared with India in this area?

Q8, How do you comment yourself? What’s your principle as a teamleader?

Q9, Could you talk something about your dreams? What’s the present dream for you now?

发表评论

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>